$MESO· SEC filing ·

MESO: Ryoncil® 84% Survival in Pediatric SR-aGvHD, 45+ Centers Onboarded, >260M Lives Covered, Adult Trial Starting

Mesoblast Limited American Depositary Shares · Now $14.86

Post-detection moves

1h
1d
3d
7d
30d

Get alerts like this in real time

Push notifications the moment a signal fires. No spam, no crypto, no fluff.

Download for iOS